Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (26651)	11/23/1998 6:47:00 PM
From: Machaon	Read Replies (1) \| Respond to of 32384

<< Ligand Launches Phase II Trial with Targretin Capsules for the Treatment of Breast Cancer >> It's about time we started getting some info from their pipeline! Does Ligand have a partnership for this product/application, or are they going it alone? Thanks, Bob

To: Henry Niman who wrote (26651)	11/23/1998 6:56:00 PM
From: Machaon	Read Replies (1) \| Respond to of 32384

From the news release: << A Phase II trial with Targretin gel for the treatment of patients with actinic keratoses and Phase IIb studies in patients with ovarian and head and neck cancers have been completed. >> Are there any results published from these "completed" phase II studies? I would think that if there were significant results, something would've been published by now. Thanks, Bob